Home Pilots DyAnsys’ neurostimulation device receives FDA clearance to treat post-cardiac surgery pain Pilots DyAnsys’ neurostimulation device receives FDA clearance to treat post-cardiac surgery pain By - September 27, 2022 39 0 Facebook Twitter Pinterest WhatsApp The company’s device, Primary Relief, is the latest of DyAnsys’ long list of devices to receive FDA clearance. RELATED ARTICLESMORE FROM AUTHOR Pilots Medtronic issues voluntary recall of MiniMed insulin pumps Pilots Hybrid primary care company Rezilient Health scores $10M Pilots Empathy Health Technologies raises $2.8M for Sober Sidekick app LEAVE A REPLY Cancel reply Please enter your comment! Please enter your name here You have entered an incorrect email address! Please enter your email address here Save my name, email, and website in this browser for the next time I comment. FOLLOW ME0FansLike0FollowersFollow0SubscribersSubscribe POPULAR ARTICLES Q&A: Best Buy Health on forming partnerships and its place in healthcare Pilots - July 14, 2023 0 b.well Connected Health scores $40M to accelerate growth Pilots - February 27, 2024 0 Roundup: Vietnamese e-pharmacy Medigo raises $2M and more digital health fundings Pilots - March 17, 2023 0 Q&A: True North ITG on investors and potential portfolio companies’ cybersecurity Pilots - September 25, 2024 0 Mesh Bio refining digital twin tech for chronic disease management and more briefs Pilots - October 20, 2023 0 POPULAR CATEGORIESPilots2166Applications750Testing283Collaborations15GitHub3